Martin Dow Group is an innovation-driven group committed to providing a broad range of high-quality medicines and formulations that deliver on the promise of better patient outcomes.
Our capabilities span a wide range of therapeutic areas, and our GMP-compliant manufacturing facilities are outfitted with robust technologies dedicated to providing consistent quality and developing high-performing Pharmaceutical and Nutraceutical products that excel in efficacy and cost-effectiveness.
Our international manufacturing facility is certified by Synadiet, Ecocert, DG CCRF, and Agriculture Biologique and adheres to the strictest international standards to provide results that satisfy our partners’ and consumers’ unmet needs.
Creating distinction for life has always been at the core of our business practices at Martin Dow. To attain this distinction, we have a quality-driven approach from manufacturing to delivering high-value products to our consumers and partners.
We have a dedicated new product development (NPD) Lab, a state-of-the-art facility recognized by the local drug regulatory body. It is equipped with the latest equipment for manufacturing, packaging, and testing new products.
At Martin Dow, we invest in cGMP compliant manufacturing technologies and state-of-the-art facilities built to international standards.